Better Health for All

Globus Medical Inc.'s core business is dedicated to the design, development, and commercialization of musculoskeletal implants and solutions, including spinal and orthopedic products.

These products are used in surgical procedures to treat various spinal disorders and improve patient care and outcomes, indicating that the entire product portfolio is devoted to health improvement. As a medical device company, KPIs related to pharmaceutical patent flexibility, nutrition and food safety, addiction mitigation, and clinical trial ethics are not applicable to its operations.

Fair Money & Economic Opportunity

Globus Medical Inc. is a medical device company, as indicated by the provided articles which detail its financial performance, share repurchases, and acquisitions related to medical technologies.

The ethical value 'Fair Money & Economic Opportunity' is designed to assess financial institutions and companies offering consumer financial services. The provided articles do not contain any specific, concrete data points or information related to consumer lending, deposit services, financial product pricing, financial literacy initiatives, or other metrics relevant to the KPIs under this value. Therefore, all KPIs are omitted due to a lack of applicable evidence.

Fair Pay & Worker Respect

For the 2024 fiscal year, Globus Medical's CEO to median employee pay ratio was 51:1

, with the CEO's total compensation at $4,858,660 and median employee pay at $95,497 . Employee reviews on Glassdoor indicate an overall satisfaction rating of 2.8 out of 5 stars (equivalent to 56/100) , with a 31% recommendation rate . The company provides a benefits package that includes competitive pay, annual incentive awards, bonus opportunities, comprehensive health and wellness programs, retirement benefits, and paid time off . As of December 31, 2024, out of over 5,300 employees worldwide , only those in one market outside the U.S. are covered by a collective bargaining agreement . Employee sentiment from reviews highlights mixed experiences, with some praising leadership and benefits , while others express concerns about fairness, lack of advancement, unkept promises regarding raises, high stress, poor work-life balance, and high turnover .

Fair Trade & Ethical Sourcing

No specific quantitative data was found in the provided articles to assess Globus Medical Inc. against the Fair Trade & Ethical Sourcing KPIs. While the company has policies and codes of conduct addressing ethical sourcing, forced/child labor, and conflict minerals

, , the articles do not provide measurable data such as percentages of fair-trade certified spend, audit frequencies, number of substantiated labor incidents, traceability coverage percentages, remediation speeds, or the percentage of supplier contracts with enforceable ethical clauses. Information regarding conflict minerals indicates some suppliers reported sourcing from covered countries , but a percentage of high-risk spend is not provided. Similarly, there is no data on supplier diversity spend.

Honest & Fair Business

Globus Medical received a warning letter from the U.S. Food and Drug Administration (FDA) on July 16, 2024,

citing deficiencies in product complaint procedures, investigations, and Medical Device Report (MDR) procedures, including failure to submit MDR reports within 30 days. However, no ethics-related regulatory fines have been reported in the past three years. The company maintains a comprehensive whistleblower policy, which includes a 24/7 anonymous hotline managed by a third-party company, available in the U.S. and most other countries, with anti-retaliation provisions and a commitment to timely investigation. Furthermore, Globus Medical has a corporate policy prohibiting improper or unethical payments to government officials globally, in accordance with the FCPA and the UK Bribery Act, which applies to all employees, distributors, and third parties, and is overseen by a Chief Compliance Officer as part of an auditable compliance program.

Kind to Animals

All participating facilities involved in animal studies are accredited by the American Association for the Accreditation of Laboratory Animal Care International (AAALACi).

The company conducts pre-clinical studies on animals to assess product safety. For these studies, all in-vivo animal studies commence following approval by the appropriate Institutional Animal Care and Use Committee (IACUC) and strictly abide by applicable regulations including the Animal Welfare Act Regulations, U.S. Public Health Service Office of Laboratory Animal Welfare Policy, and the Guide for the Care and Use of Laboratory Animals. Globus Medical also utilizes several non-animal testing methods, such as biomechanical testing, finite element analysis, computational modeling, histology, radiography, scanning electron microscopy, and particle analysis.

No War, No Weapons

Globus Medical derived approximately 0.6% of its revenue from U.S. government contracts in the four quarters ending March 2021

, which included a Defense Logistics Agency contract for orthopedic spinal trauma procedural packages and supplies . The company also has a policy stating it will not use conflict minerals unless sourced from a certified smelter , indicating a commitment to 100% conflict-free sourcing for such materials.

Zero Waste & Sustainable Products

Globus Medical Inc. implements a minimization focus for hazardous waste by requiring its suppliers to ensure that products supplied do not contain hazardous substances as listed in Section 12.5 of its Purchase Order Terms and Conditions.

The company also sets waste-related requirements for its direct suppliers, mandating them to maintain adequate controls to meet packaging requirements and to warrant compliance with all applicable laws and regulations.